Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Bongini

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2015
Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinomaFrancesca Romana Ponziani, Sherrie Bhoori, Alessandro Germini, et al.
Annals of Surgery|October 1, 2019
Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula: A Prospective Clinical StudyVincenzo Mazzaferro, Matteo Virdis, Carlo Sposito, et al.
World Journal of Gastroenterology|October 1, 2016
Development of a prognostic scoring system for resectable hepatocellular carcinomaCarlo Sposito, Stefano Di Sandro, Federica Brunero, et al.
World Journal of Gastroenterology|March 16, 2017
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patientsAlessandro Cucchetti, Carlo Sposito, Antonio Daniele Pinna, et al.
Journal of Gastroenterology and Hepatology|September 3, 2015
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinomaAntonio Facciorusso, Luigi Mariani, Carlo Sposito, et al.
Cancers|June 12, 2026
Surgical Approach to Liver Metastasis from Gastroenteropancreatic Neuroendocrine Tumors in the Era of Precision OncologyJorgelina Coppa, Simone Oldani, Sara Pusceddu, et al.
Gastroenterology|October 10, 2017
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular CarcinomaVincenzo Mazzaferro, Carlo Sposito, Jian Zhou, et al.
Hepatology (Baltimore, Md.)|August 23, 2012
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 studyVincenzo Mazzaferro, Carlo Sposito, Sherrie Bhoori, et al.
Transplantation|April 6, 2023
Surgical Treatment of Hepatocellular Carcinoma: Multicenter Competing-risk Analysis of Tumor-related Death Following Liver Resection and Transplantation Under an Intention-to-treat PerspectiveStefano Di Sandro, Carlo Sposito, Matteo Ravaioli, et al.
Journal of Hepatology|February 28, 2026
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)Sherrie Bhoori, Licia Rivoltini, David J Pinato, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2015
Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinomaFrancesca Romana Ponziani, Sherrie Bhoori, Alessandro Germini, et al.
Annals of Surgery|October 1, 2019
Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula: A Prospective Clinical StudyVincenzo Mazzaferro, Matteo Virdis, Carlo Sposito, et al.
World Journal of Gastroenterology|October 1, 2016
Development of a prognostic scoring system for resectable hepatocellular carcinomaCarlo Sposito, Stefano Di Sandro, Federica Brunero, et al.
World Journal of Gastroenterology|March 16, 2017
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patientsAlessandro Cucchetti, Carlo Sposito, Antonio Daniele Pinna, et al.
Journal of Gastroenterology and Hepatology|September 3, 2015
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinomaAntonio Facciorusso, Luigi Mariani, Carlo Sposito, et al.
Cancers|June 12, 2026
Surgical Approach to Liver Metastasis from Gastroenteropancreatic Neuroendocrine Tumors in the Era of Precision OncologyJorgelina Coppa, Simone Oldani, Sara Pusceddu, et al.
Gastroenterology|October 10, 2017
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular CarcinomaVincenzo Mazzaferro, Carlo Sposito, Jian Zhou, et al.
Hepatology (Baltimore, Md.)|August 23, 2012
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 studyVincenzo Mazzaferro, Carlo Sposito, Sherrie Bhoori, et al.
Transplantation|April 6, 2023
Surgical Treatment of Hepatocellular Carcinoma: Multicenter Competing-risk Analysis of Tumor-related Death Following Liver Resection and Transplantation Under an Intention-to-treat PerspectiveStefano Di Sandro, Carlo Sposito, Matteo Ravaioli, et al.
Journal of Hepatology|February 28, 2026
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)Sherrie Bhoori, Licia Rivoltini, David J Pinato, et al.
Pageof 3